The reason why vertical integration is important for AI investment is that if AI is commoditized, then that AI-acceleration will costs pennies for drugs that are worth billions.
I don't see how OpenAI or Google can profit from drug discovery. It's nearly pure consumer surplus (where the drug companies and patients are the consumers).